Fred Poordad, M.D., of the UT Health Science Center San Antonio and Texas Liver Institute led the ALLY-1 trial. The overall cure rate for Hepatitis C patients with a liver transplant was 94 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback